Raju S. Rajmani
Bengaluru, KA 560012, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
Helicogenic Amino Acid Increases Passive Permeability and Oral Bioavailability of Macrocycles by Preorganizing γ-Turn.
Journal: Journal of medicinal chemistry
Published: March 09, 2026
Efficient Elimination of Microbial Infections in Wounds Using Plasma-Activated Water Hydrogel.
Journal: ACS pharmacology & translational science
Published: February 16, 2026
Eco-Friendly Access to Indenodiazepinones from o‑Formylynones and o‑Phenylenediamines and Their Preliminary Antibacterial Activity.
Journal: ACS medicinal chemistry letters
Published: February 03, 2026
The antimycobacterial and healing effect of sorafenib through pro-apoptotic and immunomodulatory activities.
Journal: Microbiology spectrum
Published: January 26, 2026
Development of a Thermostable and Broadly Neutralizing Pan-Sarbecovirus Vaccine Candidate.
Journal: ACS infectious diseases
Published: December 23, 2025
Interbacterial AI-2 signaling orchestrates chemotaxis, attachment, and antimicrobial peptide resistance to promote Salmonella colonization.
Journal: iScience
Published: November 22, 2025
Nucleoid-associated protein HU constrains transcription elongation to influence cellular functions, virulence, and drug tolerance in Mycobacterium tuberculosis.
Journal: Nucleic acids research
Published: October 30, 2025
The resilience of Salmonella to bile stress is impaired due to the reduced efflux pump activity mediated by the antioxidant enzyme YqhD.
Journal: mSphere
Published: October 02, 2025
Turn-engineering tunes the conformational rigidity of β-hairpin AMPs in achieving membrane selectivity and killing drug-resistant ESKAPE pathogens.
Journal: Chemical science
Published: September 03, 2025
M. bovis FadR mutant exhibits an altered colony morphotype and increased virulence.
Journal: Tuberculosis (Edinburgh, Scotland)
Published: July 16, 2025
Antimycobacterial and immunomodulatory activities of sorafenib in a preclinical mouse model of TB infection through CD4+CD25low and CD8+CD25low effector T cells.
Journal: Frontiers in immunology
Published: March 10, 2025
Last Updated: 09/26/2026